Jump to section
Cureatr's mission is to help health plans, healthcare organizations, and patients make sure medications are taken appropriately, effectively, and most of all, safely.
54% employee growth in 12 months
Around half of all US Medicare beneficiaries are on at least five different medications. This becomes complex both for the patient to manage and for physicians to track and adjust. In fact, over 250,000 deaths annually are the result of poor drug therapy and management, and by some reports, this racks up healthcare costs of well over $500 billion.
Cureatr’s premise is to plug the gaps in the current medication management process for healthcare providers and patients alike. Its services and platforms allow physicians to pool all relevant patient data for more informed prescription and discharge decisions, and to continuously monitor and reach out to patients at any stage in their medication period. This is designed to more effectively catch prescription or management errors that otherwise lead to patient re-admissions.
The company has realized, however, that its true value can prove to be a shifting one. The Cureatr remit covers medication reconciliation, medication non-adherence, unnecessary polypharmacy, and medication management, but the company has broadened out its sales pitch to more broadly address larger issues its platform can solve. Its recent acquisition of SinfoníaRx will allow it to futher scale its services and solidify its leading position in the telepharmacy sector.
Kirsty
Company Specialist at Welcome to the Jungle
Aug 2023
$7.6m
LATE VC
May 2022
$9.4m
LATE VC
Alex Khomenko
(CSO)Completed a computer science masters at Stanford, and has subsequently worked as principal team architect at PayPal and director of engineering at 23andMe.
Joseph Mayer
(Board Member)Previous Founder of Unwired Holdings, and Co-founder and Chief Medical Officer at Inomaly, Inc. Current Managing Partner at Diagram HC and President at onehome, recently acquired by Humana.